- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
Ensysce Biosciences is a shell companies business based in the US. Ensysce Biosciences shares (LACQ) are listed on the PINK and all prices are listed in US Dollars.
What's in this guide?
Our top picks for where to buy Ensysce Biosciences stock
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Complimentary access to a financial planner
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
How to buy Ensysce Biosciences stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – LACQ. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Ensysce Biosciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Ensysce Biosciences stock price (PINK: LACQ)
Use our graph to track the performance of LACQ stocks over time.Ensysce Biosciences shares at a glance
52-week range | $0.00 - $0.00 |
---|---|
50-day moving average | $13.97 |
200-day moving average | $13.65 |
Wall St. target price | N/A |
PE ratio | 118.7705 |
Dividend yield | N/A |
Earnings per share (TTM) | $0.12 |
Is Ensysce Biosciences stock undervalued or overvalued?
Valuing Ensysce Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ensysce Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ensysce Biosciences's P/E ratio
Ensysce Biosciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 119x. In other words, Ensysce Biosciences shares trade at around 119x recent earnings.
Ensysce Biosciences financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -1.25% |
Return on equity TTM | 23.4% |
Profit margin | 0% |
Book value | $0.30 |
Market Capitalization | $90.2 million |
TTM: trailing 12 months
Ensysce Biosciences share dividends
We're not expecting Ensysce Biosciences to pay a dividend over the next 12 months.
Ensysce Biosciences share price volatility
Over the last 12 months, Ensysce Biosciences's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Ensysce Biosciences's is -0.1134. This would suggest that Ensysce Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Ensysce Biosciences has bucked the trend.
Ensysce Biosciences overview
Ensysce Biosciences, Inc. operates as a biotechnology company that develops abuse-resistant drug technologies. It offers TAAP, a trypsin-activated abuse protection technology that prevents abuse through a two-step internal trypsin-activation process to meet the medical needs of patients living with chronic pain; and MPAR, a multi-pill abuse resistant technology that provides a layer of protection for overdose. The company was incorporated in 2003 and is based in La Jolla, California. .
Frequently asked questions
What percentage of Ensysce Biosciences is owned by insiders or institutions?Currently 39.841% of Ensysce Biosciences shares are held by insiders and 56.672% by institutions. When does the fiscal year end for Ensysce Biosciences?
Ensysce Biosciences's fiscal year ends in December. Where is Ensysce Biosciences based?
Ensysce Biosciences's address is: 7946 IVANHOE AVENUE, La Jolla, CA, United States, 92037 What is Ensysce Biosciences's ISIN number?
Ensysce Biosciences's international securities identification number is: US2936021086 What is Ensysce Biosciences's CUSIP number?
Ensysce Biosciences's Committee on Uniform Securities Identification Procedures number is: 52539T107
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to gift stock
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
Acorns review 2024
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.
Ask a question